Status:
COMPLETED
Effect of Indoor Plants on Cardiopulmonary System
Lead Sponsor:
Lina Zhang
Collaborating Sponsors:
Zhejiang Chinese Medical University
Conditions:
Cardiopulmonary
Eligibility:
All Genders
18-35 years
Phase:
NA
Brief Summary
This is a randomized controlled human exposure crossover study, aims to explore the health benefits of indoor plants on cardiopulmonary system on adults.
Detailed Description
The researchers will conduct a randomized cross-controlled trial involving 48 healthy adults in Hangzhou, China. These participants will be randomly assigned into two groups, each comprising 24 indivi...
Eligibility Criteria
Inclusion
- Living in Hangzhou during the study period;
- Non-smoking, no history of alcohol or drug abuse;
- Staying indoors in daytime we required.
Exclusion
- Current or ever smokers;
- Subjects with allergic disease, such as allergic rhinitis, allergic asthma, and atopy;
- Subjects with cardiovascular disease, such as congenital heart disease, pulmonary heart disease, and hypertension;
- Subjects with respiratory disease, such as asthma, chronic bronchitis, and chronic obstructive pulmonary disease;
- Subjects with chronic disease, such as diabetes, chronic hepatitis, and kidney disease;
- Subjects with a history of major surgery;
- Medication use or dietary supplements intake in recent two months;
- Unable to cooperate with follow-up.
Key Trial Info
Start Date :
December 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2024
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT06060145
Start Date
December 21 2023
End Date
March 31 2024
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhejiang Chinese Medicine University
Huangzhou, Zhejiang, China, 310000